The development of the transhepatic porto-systemic venous shunt(THPVS) for the portal hypertensio
Phase 1
Recruiting
- Conditions
- portal hypertension
- Registration Number
- JPRN-UMIN000027871
- Lead Sponsor
- Osaka general medical center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with unpuncturable organ on the puncture line on images. 2.Patients with obvious tendency of bleeding or coagulation disorder. 3.Patients with antiplatelet, thrombolysis or anticoagulation therapy. 4.Patients who are judged inappropriate by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method severe or unexpected adverse events within 4 weeks
- Secondary Outcome Measures
Name Time Method